Immunization with an HIV-1 immunogen induces CD4+ and CD8+ HIV-1-specific polyfunctional responses in patients with chronic HIV-1 infection receiving antiretroviral therapy. (Q51965254)

From Wikidata

Jump to navigation Jump to search

scientific article published in April 2008

Language	Label	Description	Also known as
English	Immunization with an HIV-1 immunogen induces CD4+ and CD8+ HIV-1-specific polyfunctional responses in patients with chronic HIV-1 infection receiving antiretroviral therapy.	scientific article published in April 2008

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/18433946

Immunization with an HIV-1 immunogen induces CD4+ and CD8+ HIV-1-specific polyfunctional responses in patients with chronic HIV-1 infection receiving antiretroviral therapy. (English)

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/18433946

anti-retroviral agent

0 references

0 references

3

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/18433946

author name string

L Valor

1

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/18433946

J Navarro

2

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/18433946

C Rodríguez-Sáinz

4

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/18433946

J Gil

5

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/18433946

F López

6

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/18433946

E Fernández-Cruz

7

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/18433946

STIR-2102 Team

8

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/18433946

language of work or name

0 references

publication date

1 April 2008

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/18433946

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/18433946

26

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/18433946

22

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/18433946

2738-2745

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/18433946

Influence of HLA-B57 on clinical presentation and viral control during acute HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.019

7 January 2021

The Role of CD4(+) and CD8(+) T Cells in Controlling HIV Infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.019

7 January 2021

Persistent recognition of autologous virus by high-avidity CD8 T cells in chronic, progressive human immunodeficiency virus type 1 infection.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.019

7 January 2021

CD8+ T cells from most HIV-1-infected patients, even when challenged with mature dendritic cells, lack functional recall memory to HIV gag but not other viruses.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.019

7 January 2021

Functional heterogeneity of cytokines and cytolytic effector molecules in human CD8+ T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.019

7 January 2021

HIV-1-specific IFN-gamma/IL-2-secreting CD8 T cells support CD4-independent proliferation of HIV-1-specific CD8 T cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.019

7 January 2021

Therapeutic vaccination against HIV.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.019

7 January 2021

Clinical experience with therapeutic AIDS vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.019

7 January 2021

Immune deficiency in HIV-1 infection: novel therapeutic approaches targeting innate and adaptive responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.019

7 January 2021

Therapeutic immunization with an inactivated HIV-1 Immunogen plus antiretrovirals versus antiretroviral therapy alone in asymptomatic HIV-infected subjects

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.019

7 January 2021

The potential role of the HIV-1 immunogen (Remune) as a therapeutic vaccine in the treatment of HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.019

7 January 2021

Immunization with vaccinia virus induces polyfunctional and phenotypically distinctive CD8(+) T cell responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.019

7 January 2021

A dendritic cell-based vaccine for treating HIV infection: background and preliminary results

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.019

7 January 2021

Loss of HIV-1-specific CD8+ T cell proliferation after acute HIV-1 infection and restoration by vaccine-induced HIV-1-specific CD4+ T cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.019

7 January 2021

Carboxyfluorescein succinimidyl ester-based proliferative assays for assessment of T cell function in the diagnostic laboratory

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.019

7 January 2021

MHC class II tetramers identify peptide-specific human CD4(+) T cells proliferating in response to influenza A antigen

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.019

7 January 2021

Following the fate of individual T cells throughout activation and clonal expansion. Signals from T cell receptor and CD28 differentially regulate the induction and duration of a proliferative response

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.019

7 January 2021

A recombinant vaccinia virus based ELISPOT assay detects high frequencies of Pol-specific CD8 T cells in HIV-1-positive individuals

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.019

7 January 2021

Highly attenuated vaccinia virus mutants for the generation of safe recombinant viruses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.019

7 January 2021

Loss of HIV-1-specific T cell proliferation in chronic HIV-1 infection: cause or consequence of viral replication?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.019

7 January 2021

High-level HIV-1 viremia suppresses viral antigen-specific CD4(+) T cell proliferation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.019

7 January 2021

Diminished Proliferation of Human Immunodeficiency Virus-Specific CD4+T Cells Is Associated with Diminished Interleukin-2 (IL-2) Production and Is Recovered by Exogenous IL-2

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.019

7 January 2021

Changes in Frequency of HIV‐1–Specific Cytotoxic T Cell Precursors and Circulating Effectors after Combination Antiretroviral Therapy in Children

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.019

7 January 2021

Persistent high frequency of human immunodeficiency virus-specific cytotoxic T cells in peripheral blood of infected donors

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.019

7 January 2021

Human immunodeficiency virus type 1-specific cytotoxic T lymphocyte activity is inversely correlated with HIV type 1 viral load in HIV type 1-infected long-term survivors

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.019

7 January 2021

Enhancement of HIV Type 1 Antigen-Specific CD4+ T Cell Memory in Subjects with Chronic HIV Type 1 Infection Receiving an HIV Type 1 Immunogen.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.019

7 January 2021

Predictors of HIV-specific lymphocyte proliferative immune responses induced by therapeutic vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.019

7 January 2021

HIV-1-Specific CD4 helper function in persons with chronic HIV-1 infection on antiviral drug therapy as measured by ELISPOT after treatment with an inactivated, gp120-depleted HIV-1 in incomplete Freund's adjuvant

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.019

7 January 2021

A randomized, placebo-controlled study of the immunogenicity of human immunodeficiency virus (HIV) rgp160 vaccine in HIV-infected subjects with > or = 400/mm3 CD4 T lymphocytes (AIDS Clinical Trials Group Protocol 137).

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.019

7 January 2021

Immunologic and virologic effects of subcutaneous interleukin 2 in combination with antiretroviral therapy: A randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.019

7 January 2021

Nadir CD4+ T-cell count and numbers of CD28+ CD4+ T-cells predict functional responses to immunizations in chronic HIV-1 infection.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.019

7 January 2021

A phase I, randomized study of combined IL-2 and therapeutic immunisation with antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.019

7 January 2021

HIV-1 specific CD8+ T cells with an effector phenotype and control of viral replication

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.019

7 January 2021

Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.019

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2008.03.019

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/18433946

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/18433946

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51965254&oldid=2144770005"